Health Care/Hospital
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-18 08:00
2202
Promising Efficacy of AT101 CAR-T for Blood Cancer
SEOUL, South Korea, April 17, 2023 /PRNewswire/ -- AbClon, a South Korean biotech firm, presented non-clinical and phase 1 interim results of its AT101 novel CAR-T therapy at the annual 2023 AACR conference. AT101 targets the CD19 protein for treatment of blood cancer. AT101 demonstrated superio...
2023-04-18 02:00
1679
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2022
BEIJING, April 17, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...
2023-04-17 20:24
2465
Orion Health launches Orchestral - a once in a generation giant leap forward for health data
Orchestral reimagines the aggregation of data and how it is used in healthcare in the modern machine learning era. AUCKLAND, New Zealand, April 17, 2023 /PRNewswire/ -- The Orchestral health intelligence platform, announced at HIMSS23, is the biggest step forward in health data since the advent ...
2023-04-17 20:00
1779
Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions
SHANGHAI, April 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases, today released its 2022 annual report. Whil...
2023-04-17 18:30
1956
Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development
TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announces today thatBassem Elmankabadi, M.D. joins Foresee as a Senior Vice President of Clinical Development. Dr. Bassem Elmankabadi is a Board Certified Surgeon with over 17 years of clinical backg...
2023-04-17 16:50
1663
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 16, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-17 08:20
3119
Introducing the MetaSight® G200: A Revolutionary Third-Generation Chromosomal Karyotyping System Transforming Global Chromosomal Analysis
CHANGSHA, China, April 15, 2023 /PRNewswire/ -- The MetaSight® G200 is a groundbreaking karyotyping system based on high-resolution microscopy technology, capable of accurately detecting chromosomal abnormalities in humans. This innovative system aids doctors in diagnosing and treating diseases ...
2023-04-15 14:43
3123
Meihua International Medical Technologies Co., Ltd. Reports 2022 Financial Year Results
YANGZHOU, China, April 14, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial r...
2023-04-14 20:45
3966
Minghui Pharmaceutical Inc. Announces Phase 2 Clinical Trial Success of MH004 Cream as a Potential Best-in-Class Topical Treatment for Mild-to-Moderate Atopic Dermatitis and the FDA Clearance of its Global Phase 3 MRCT
* Study met both primary and all key secondary endpoints * Mean percentage change from baseline in Eczema Area and Severity Index (EASI) score was -78.7% in 1.0% MH004 Cream-treated group compared to -46.7% in vehicle group * 79.6% individuals treated with 1.0% MH004 Cream achieved EASI-75 c...
2023-04-14 19:00
6504
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults
NANJING, China, April 13, 2023 /PRNewswire/ -- On April 1st, 2023, during the First Infection Collaboration Forum of the Chinese National Center for Infectious Diseases, Nanjing Zenshine Pharmaceuticals Co., Ltd. (Zenshine Pharmaceuticals) announced that its proprietary anti-influenza agent ZX-71...
2023-04-14 01:15
1999
Healint and King's College London Announce a Ground-breaking Study on the Interaction between Sleep and Migraine in a Large Global Sample
PALO ALTO, Calif., April 13, 2023 /PRNewswire/ -- Healint, a digital health company specializing in Central Nervous System disease management has partnered with King's College London to conduct a ground-breaking study on the relationship between sleep and migraine. The study, which collected anon...
2023-04-13 20:00
1514
Viva Biotech Attended SAPA-China
HONG KONG, April 12, 2023 /PRNewswire/ -- 6th-7th April, the "2022 SAPA-China Annual Conference - Opportunities and Challenges for the Development ofChina's Biopharmaceutical Industry" hosted by The Sino-American Pharmaceutical Professionals Association (SAPA) was held inChengdu, Sichuan. Viva Bi...
2023-04-13 11:33
2274
Smart Physiotherapy Systems: One-Stop Solution for Pain Patients
WUHAN, China, April 12, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based inWuhan and Dusseldorf, reported the great improvement of Smart Physiotherapy Systems that were launched several ...
2023-04-13 11:10
1741
Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis
SEONGNAM, South Korea and CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis, cancer, and inflammation, announced it has dosed the first patient in its Phase 2a clinical study...
2023-04-13 06:00
1871
Standigm announces Younsung Choo as chief executive officer
Former LG life Sciences exec and long-time Standigm advisor brings extensive
experience in pharmaceuticals and project management
SEOUL, South Korea, April 12, 2023 /PRNewswire/ -- Standigm
2023-04-13 00:07
2072
Health In Tech Partners With 6 Degrees Health to Accelerate Implementation of Level-Funded Health Plans with Transparency, Control, and Predictability
Brokers and Employers with groups ranging from 5-150 lives will benefit from the partnership's fully integrated, solution-based products for the level-funded healthcare market. STUART, Fla., April 12, 2023 /PRNewswire/ -- Health in Tech ("HIT", or "the Company"), the industry-leading insurtech c...
2023-04-12 20:30
1763
CHITOSE Group Obtains Funding from Japanese Government-affiliated NEDO for Green Innovation Fund of USD400M Range
KAWASAKI, Japan and SINGAPORE, April 12, 2023 /PRNewswire/ -- Chitose Laboratory Corp., the core company of the CHITOSE Group (hereinafter "CHITOSE"), has won funding from a Japanese government-affiliated entity for a project on the self-proposed theme of "Building a global industry originating ...
2023-04-12 14:17
1910
Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia
SINGAPORE, April 11, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner with CTTQ-Akeso ( Shanghai) Biomed. Tech. Co., Ltd. (CTTQ-Akeso)（jointly established by Akeso, Inc. (9926.HK, Akeso) and Chia Tai Tianqing Pharmaceutical Group Co...
2023-04-12 06:00
2248
Lunit Demonstrates Progress in the Development of Novel Diagnostics at the 2023 AACR Annual Meeting
* Lunit and collaborators demonstrate key progress in the development of novel diagnostics for cancer therapies, including immuno-oncology, in addition to molecular targeted agents and antibody-drug conjugates * Presentations to deliver new research using Lunit SCOPE in a wide range of cancer...
2023-04-11 21:00
2006
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12035
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8090
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
7831
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7248
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5581